Company intelligence / Profile preview

CD Capital

Beijing, Beijing, Chinapinnaclesdx.com ↗

Ownership: Private
Development stage: Other

Overview

CD Capital (“辰德资本”) is a leading Chinese private equity and venture capital firm specializing in healthcare and life sciences investments. The firm focuses primarily on innovative biopharmaceuticals and medical technology sectors within China and globally. It has backed numerous high-profile biotech startups at various development stages.

Modalities: Small moleculeBiologicMonoclonal antibodyCell therapyGene therapy
Industry: Investors

Beyond the preview

Go deeper on CD Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CD Capital.

Explore the full profile